A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Basic Science and Pathogenesis. | LitMetric

Background: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a common cause of dementia in older age. LATE-NC was first coined in 2019 with proposed staging criteria of TDP-43 progressing from amygdala (stage 1), to hippocampus (stage 2), to middle frontal gyrus (stage 3). Criteria were updated in 2023 to further categorize stage 1 to either TDP-43 inclusions in amygdala alone (stage 1a) or hippocampus alone (stage 1b). We applied this updated LATE-NC staging criteria to data from participants in the National Alzheimer's Coordinating Center (NACC) and examined associations with clinical diagnosis and other neuropathologic changes (NCs).

Method: We selected participants in NACC with regional TDP-43 assessments, excluding those with frontotemporal dementia-related and rare NCs, or with a non-Alzheimer's disease (AD) etiologic clinical diagnosis. LATE-NC stages were assigned according to updated criteria. We performed logistic regressions with LATE-NC stages as predictors and clinical diagnosis (dementia, cognitive impairment, memory impairment), other neuropathologic changes (ADNC, Lewy bodies, hippocampal sclerosis of aging (HS-A), and vascular NCs), or gross atrophy at autopsy (cortical, hippocampal, frontal/temporal lobar) as outcomes. We also examined the association of LATE-NC stages with dementia and memory impairment while accounting for other NCs.

Result: Of N = 1365 participants, LATE-NC was present in 519 (37%): 31% stage 1 (78% 1a, 22% 1b), 56% stage 2, 13% stage 3 (Table-1). Participants with stage 1a were younger at death compared to higher stages. Stage 1a and 1b had similar associations with cognitive problems (Figure-1). However, while other stages were associated with ADNC and Lewy bodies, stage 1b was not. Meanwhile stage 1b was associated with HS-A more strongly than stage 1a and to a similar degree as stage 2. We observed expected associations of higher LATE-NC stages with dementia and other NCs (Figure-1). Lastly, LATE-NC stage 1b was significant (and stage 1a trended) for associations with dementia and memory impairment, while higher LATE-NC stages had associations eclipsed in strength only by highest level ADNC (Figure-2).

Conclusion: These findings highlight the utility of the updated LATE-NC staging criteria in general, and stage 1 subtypes in particular, in capturing broad associations with cognitive impairment and specific associations with other neuropathologic changes.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.086019DOI Listing

Publication Analysis

Top Keywords

late-nc stages
20
stage
18
staging criteria
12
clinical diagnosis
12
neuropathologic changes
12
memory impairment
12
late-nc
11
amygdala stage
8
stage hippocampus
8
hippocampus stage
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!